Takeda Shaves Off European Subsidiaries And U.S. Jobs On Japanese Approval Day
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo's Denosumab and Bayer's Xarelto will soon make their appearance in the Japanese market.